[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.168.204. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
June 30, 1975

Antibiotic Batch Certification and Bioequivalence

Author Affiliations

From the Clinical Bioavailability Unit, The Upjohn Co., Kalamazoo, Mich.

JAMA. 1975;232(13):1349-1351. doi:10.1001/jama.1975.03250130033016
Abstract

All antibiotics marketed in the United States must undergo batch certification by the Food and Drug Administration. It is often assumed that the different brands of a particular antibiotic that pass in vitro batch certification tests have equal in vivo bioavailability. The fallacy of this assumption is clearly supported for commercially available lots of tetracycline hydrochloride that had passed batch certification tests yet had different serial serum concentrations.

(JAMA 232:1349-1351, 1975)

×